Insight Molecular Diagnostics (IMDX) Tax Rate (2020 - 2021)

Insight Molecular Diagnostics (IMDX) posted Tax Rate of 0.27% for Q4 2021, down 98.14% sequentially from 14.6% in Q2 2021, and up 273.0% YoY from 0.07% in Q4 2020.

Insight Molecular Diagnostics (IMDX) Tax Rate (2020 - 2021) Analysis & Trends

Insight Molecular Diagnostics has reported Tax Rate for 2 years, with the latest figure at 0.27% in Q4 2021.

  • Quarterly Tax Rate rose 273.0% year-over-year to 0.27% in Q4 2021, while the trailing twelve-month figure through Sep 2024 was 0.25% (changed N/A YoY) and the FY2022 annual result came in at 6.45%, down 1107.0% from the prior year.
  • Tax Rate slipped to 0.27% in Q4 2021 per IMDX's latest filing, from 14.6% in the prior quarter.
  • Over five years, Tax Rate peaked at 65.87% in Q1 2021 and troughed at 12.41% in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Thermo Fisher Scientific 213.78 Bn 209.71 Bn 8.34 Bn 8.68%
2 Danaher 139.83 Bn 135.48 Bn 3.61 Bn 19.29%
3 Idexx Laboratories 45.99 Bn 45.79 Bn 779.09 Mn 18.89%
4 Agilent Technologies 39.69 Bn 37.88 Bn 990.00 Mn 16.91%
5 Iqvia Holdings 39.31 Bn 37.23 Bn 1.44 Bn 19.93%
6 Natera 38.74 Bn 37.64 Bn 696.04 Mn -0.35%
7 Illumina 29.94 Bn 28.77 Bn 770.00 Mn 20.38%
8 Mettler Toledo International 28.55 Bn 28.50 Bn 650.22 Mn 19.52%
9 Quest Diagnostics 26.18 Bn 25.55 Bn 1.03 Bn 21.36%
10 Insight Molecular Diagnostics 172.60 Mn 143.67 Mn 15,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2021 0.27%
Dec 31, 2021 0.27%
Dec 31, 2021 0.27%
Jun 30, 2021 14.60%
Jun 30, 2021 14.60%
Jun 30, 2021 14.60%
Mar 31, 2021 65.87%
Mar 31, 2021 65.87%
Mar 31, 2021 65.87%
Dec 31, 2020 -2.46%
Dec 31, 2020 -2.46%
Dec 31, 2020 -2.46%
Jun 30, 2020 24.04%
Jun 30, 2020 24.04%
Jun 30, 2020 24.04%
Mar 31, 2020 -12.41%
Mar 31, 2020 -12.41%
Mar 31, 2020 -12.41%